Articles - January 1, 1998 - American Family Physician


	Departments \| Patient Information

Articles

57 Management of Inflammatory Bowel Disease
V. ALIN BOTOMAN, M.D., GREGORY F. BONNER, M.D., and DANIELA A. BOTOMAN, M.D.
Advances in the management of inflammatory bowel disease include the newer 5-aminosalicylic acid compounds and corticosteroid analogs with fewer side effects.

Patient information: "Learning to Live with Inflammatory Bowel Disease," p. 71

73 Cardiovascular medicine update
Practical Considerations in the Early Treatment of Ischemic Stroke
JOSEPH P. BROERICK, M.D.
The major causes of delay in treatment of patients with ischemic stroke are failure, on the part of patients and family, to recognize symptoms, and failure to access the medical system most efficiently. Guidelines for evaluation and treatment of potential stroke patients are presented, as well as goal times for arrival-to-treatment intervals.

85 Practical Therapeutics
Oral Poisonings: Guidelines for Initial Evaluation and Treatment
LARS C. LARSEN, M.D., and DOYLE M. CUMMINGS, PHARM.D.
A comprehensive clinical assessment and an understanding of available treatment methods are essential in the initial management of patients with oral poisonings.

93 Latex Allergy
SUMANA REDDY, M.D.
For latex-allergic patients and health care providers, avoidance of latex is key in allergy management.

Patient information: "Latex Allergy," p. 101

107 Clinical Pharmacology
Cytochrome P450: New Nomenclature and Clinical Implications
MELANIE JOHNS CUPP, PHARM.D., and TIMOTHY S. TRACY, PH.D.
An understanding of the unique characteristics of the various cytochrome P450 enzymes is useful in predicting, understanding and managing drug interactions.

Copyright © 1998 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.

January 1, 1998 Contents | Subscribe | Search | AFP Home Page

	Articles
57	Management of Inflammatory Bowel Disease V. ALIN BOTOMAN, M.D., GREGORY F. BONNER, M.D., and DANIELA A. BOTOMAN, M.D. Advances in the management of inflammatory bowel disease include the newer 5-aminosalicylic acid compounds and corticosteroid analogs with fewer side effects.
	Patient information: "Learning to Live with Inflammatory Bowel Disease," p. 71
73	Cardiovascular medicine update Practical Considerations in the Early Treatment of Ischemic Stroke JOSEPH P. BROERICK, M.D. The major causes of delay in treatment of patients with ischemic stroke are failure, on the part of patients and family, to recognize symptoms, and failure to access the medical system most efficiently. Guidelines for evaluation and treatment of potential stroke patients are presented, as well as goal times for arrival-to-treatment intervals.
85	Practical Therapeutics Oral Poisonings: Guidelines for Initial Evaluation and Treatment LARS C. LARSEN, M.D., and DOYLE M. CUMMINGS, PHARM.D. A comprehensive clinical assessment and an understanding of available treatment methods are essential in the initial management of patients with oral poisonings.
93	Latex Allergy SUMANA REDDY, M.D. For latex-allergic patients and health care providers, avoidance of latex is key in allergy management.
	Patient information: "Latex Allergy," p. 101
107	Clinical Pharmacology Cytochrome P450: New Nomenclature and Clinical Implications MELANIE JOHNS CUPP, PHARM.D., and TIMOTHY S. TRACY, PH.D. An understanding of the unique characteristics of the various cytochrome P450 enzymes is useful in predicting, understanding and managing drug interactions.